Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with limited treatment options. Recently, there has been a growing interest in immunotherapy with immune checkpoint inhibitors (ICIs) in TNBC, leading to extensive preclinical and clinical research. This review summari...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchimiak, Katarzyna, Badowska-Kozakiewicz, Anna M., Sobiborowicz-Sadowska, Aleksandra, Deptała, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201309/
https://www.ncbi.nlm.nih.gov/pubmed/35721387
http://dx.doi.org/10.1177/11795549221099869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201309/
https://www.ncbi.nlm.nih.gov/pubmed/35721387
http://dx.doi.org/10.1177/11795549221099869

Ejemplares similares